Top compounds associated with response to B9D1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA WZ3105 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA NG-25 GDSC1000 pan-cancer AAC -0.1 0.001
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.12 0.002
mRNA YM201636 GDSC1000 pan-cancer AAC -0.1 0.002
mRNA BHG712 GDSC1000 pan-cancer AAC -0.099 0.002
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.098 0.003
Download CSV